AGEhIV Cohort Study Group[Corporate Author] - Search Results

Year	Number of Results
2014	2
2015	2
2016	5
2017	2
2018	1
2021	1
2024	1

1

Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study.

Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE, Prins M, Reiss P; AGEhIV Cohort Study Group. Schouten J, et al. Clin Infect Dis. 2014 Dec 15;59(12):1787-97. doi: 10.1093/cid/ciu701. Epub 2014 Sep 2. Clin Infect Dis. 2014. PMID: 25182245

2

Generally rare but occasionally severe weight gain after switching to an integrase inhibitor in virally suppressed AGEhIV cohort participants.

Verboeket SO, Boyd A, Wit FW, Verheij E, Schim van der Loeff MF, Kootstra N, van der Valk M, Reiss P; AGEhIV Cohort Study Group. Verboeket SO, et al. PLoS One. 2021 May 5;16(5):e0251205. doi: 10.1371/journal.pone.0251205. eCollection 2021. PLoS One. 2021. PMID: 33951089 Free PMC article.

3

Impact of comorbidity and ageing on health-related quality of life in HIV-positive and HIV-negative individuals.

Langebeek N, Kooij KW, Wit FW, Stolte IG, Sprangers MAG, Reiss P, Nieuwkerk PT; AGEhIV Cohort Study Group. Langebeek N, et al. AIDS. 2017 Jun 19;31(10):1471-1481. doi: 10.1097/QAD.0000000000001511. AIDS. 2017. PMID: 28574965

4

Higher Prevalence of Hypertension in HIV-1-Infected Patients on Combination Antiretroviral Therapy Is Associated With Changes in Body Composition and Prior Stavudine Exposure.

van Zoest RA, Wit FW, Kooij KW, van der Valk M, Schouten J, Kootstra NA, Wiersinga WJ, Prins M, van den Born BJ, Reiss P; AGEhIV Cohort Study Group. van Zoest RA, et al. Clin Infect Dis. 2016 Jul 15;63(2):205-13. doi: 10.1093/cid/ciw285. Epub 2016 May 3. Clin Infect Dis. 2016. PMID: 27143668

5

Liver fibrosis in HIV-infected individuals on long-term antiretroviral therapy: associated with immune activation, immunodeficiency and prior use of didanosine.

Kooij KW, Wit FW, van Zoest RA, Schouten J, Kootstra NA, van Vugt M, Prins M, Reiss P, van der Valk M; AGEhIV Cohort Study Group. Kooij KW, et al. AIDS. 2016 Jul 17;30(11):1771-80. doi: 10.1097/QAD.0000000000001119. AIDS. 2016. PMID: 27088320

6

HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls.

Kooij KW, Wit FW, Schouten J, van der Valk M, Godfried MH, Stolte IG, Prins M, Falutz J, Reiss P; AGEhIV Cohort Study Group. Kooij KW, et al. AIDS. 2016 Jan;30(2):241-50. doi: 10.1097/QAD.0000000000000910. AIDS. 2016. PMID: 26684821

7

HIV-Associated Neuroretinal Disorder in Patients With Well-Suppressed HIV-Infection: A Comparative Cohort Study.

Demirkaya N, Wit FW, van Den Berg TJ, Kooij KW, Prins M, Schlingemann RO, Abramoff MD, Reiss P, Verbraak FD; AGEhIV Cohort Study Group. Demirkaya N, et al. Invest Ophthalmol Vis Sci. 2016 Mar;57(3):1388-97. doi: 10.1167/iovs.15-18537. Invest Ophthalmol Vis Sci. 2016. PMID: 27018841 Clinical Trial.

8

HIV-1 status is independently associated with decreased erectile function among middle-aged MSM in the era of combination antiretroviral therapy.

Dijkstra M, van Lunsen RHW, Kooij KW, Davidovich U, van Zoest RA, Wit FWMN, Prins M, Reiss P, Schim van der Loeff MF; AGEhIV Cohort Study Group. Dijkstra M, et al. AIDS. 2018 Jun 1;32(9):1137-1146. doi: 10.1097/QAD.0000000000001800. AIDS. 2018. PMID: 29746318

9

A biomarker profile reflective of preserved thymic function is associated with reduced comorbidities in ageing people with HIV: an AGEhIV Cohort analysis.

Vanbellinghen MC, Boyd A, Kootstra NA, Schim van der Loeff MF, van der Valk M, Reiss P; AGEhIV Cohort study group: Scientific oversight and coordination; Data management; Statistical support; Central laboratory support; Project management and administrative support; Participating HIV physicians and nurses:; Other collaborators:. Vanbellinghen MC, et al. J Infect Dis. 2024 Dec 10:jiae603. doi: 10.1093/infdis/jiae603. Online ahead of print. J Infect Dis. 2024. PMID: 39658325

10

Suboptimal primary and secondary cardiovascular disease prevention in HIV-positive individuals on antiretroviral therapy.

van Zoest RA, van der Valk M, Wit FW, Vaartjes I, Kooij KW, Hovius JW, Prins M, Reiss P; AGEhIV Cohort Study Group. van Zoest RA, et al. Eur J Prev Cardiol. 2017 Aug;24(12):1297-1307. doi: 10.1177/2047487317714350. Epub 2017 Jun 5. Eur J Prev Cardiol. 2017. PMID: 28578613 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year